Biomedical Engineering Reference
In-Depth Information
Cell cultures should be highly standardized and culture media and each component used
should be certified for this kind of use. Which cell population will perform better and which
culture technology (traditional plastic, bioreactors etc.) will provide us with the best cell prepa-
ration at the lowest cost and at the highest qualitative standards are the points that cell biolo-
gists and biotechnologists will have to solve in the next future. Convenient quality criteria and
controls will have to be established. Scaffold also will have to evolve to meet the requirements
of the clinics; future biomaterials will have possibly to have geometry specifically designed for
hosting cell and allow their survival and a better vascularisation once delivered at the implant
site in vivo. Scaffolds will have to improve in order to have resorption rates adequate to the
specific application and possibly to became at least at some extent more workable and allow
some movement (flexion, torsion, compression etc.).
References
1. Durand JL, Renier D, Marchac D. The history of cranioplasty. Ann Chir Plast Esthet 1997;
42:75-83.
2. Glicenstein J. History of bone reconstruction. Ann Chir Plast Esthet 2000; 45:171-4.
3. Mankin HJ, Gebhardt MC, Jennings LC et al. Long-term results of allograft replacement in the
management of bone tumors. Clin Orthop 1996; 86-97.
4. Springfield DS. Allograft reconstructions. Semin Surg Oncol 1997; 13:11-7.
5. Voggenreiter G, Klaes W, Assenmacher S et al. Massive intercalary bone allografts in the treatment
of primary and secondary bone tumors. A report on 21 cases. Arch Orthop Trauma Surg 1995;
114:308-18.
6. Malizos KN, Nunley JA, Goldner RD et al. Free vascularized fibula in traumatic long bone defects
and in limb salvaging following tumor resection: Comparative study. Microsurgery 1993; 14:368-74.
7. Ozaki T, Hillmann A, Wuisman P et al. Reconstruction of tibia by ipsilateral vascularized fibula
and allograft. 12 cases with malignant bone tumors. Acta Orthop Scand 1997; 68:298-301.
8. Arai K, Toh S, Tsubo K et al. Complications of vascularized fibula graft for reconstruction of long
bones. Plast Reconstr Surg 2002; 109:2301-6.
9. Norman-Taylor FH, Santori N, Villar RN. The trouble with bone allograft. Bmj 1997; 315:498.
10. Seiler 3rd JG, Johnson J. Iliac crest autogenous bone grafting: Donor site complications. J South
Orthop Assoc 2000; 9:91-7.
11. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity. A statis-
tical evaluation. Spine 1995; 20:1055-60.
12. Kurz LT, Garfin SR, Booth Jr RE. Harvesting autogenous iliac bone grafts. A review of complica-
tions and techniques. Spine 1989; 14:1324-31.
13. Kumta SM, Kendal N, Lee YL et al. Bacterial colonization of bone allografts related to increased
interval between death and procurement: An experimental study in rats. Arch Orthop Trauma
Surg 1997; 116:496-7.
14. Sutherland AG, Raafat A, Yates P et al. Infection associated with the use of allograft bone from
the north east Scotland Bone Bank. J Hosp Infect 1997; 35:215-22.
15. Rose FR, Oreffo RO. Bone tissue engineering: Hope vs hype. Biochem Biophys Res Commun
2002; 292:1-7.
16. Laurencin CT, Ambrosio AM, Borden MD et al. Tissue engineering: Orthopedic applications.
Annu Rev Biomed Eng 1999; 1:19-46.
17. Bianco P, Robey PG. Stem cells in tissue engineering. Nature 2001; 414:118-21.
18. Bucholz RW. Nonallograft osteoconductive bone graft substitutes. Clin Orthop 2002; 44-52.
19. Olsen BR, Reginato AM, Wang W. Bone development. Annu Rev Cell Dev Biol 2000; 16:191-220.
20. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development.
Dev Cell 2002; 2:389-406.
21. Wagner EF, Karsenty G. Genetic control of skeletal development. Curr Opin Genet Dev 2001;
11:527-32.
22. Bruder SP, Kraus KH, Goldberg VM et al. The effect of implants loaded with autologous mesen-
chymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 1998;
80:985-96.
23. Kon E, Muraglia A, Corsi A et al. Autologous bone marrow stromal cells loaded onto porous
hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed
Mater Res 2000; 49:328-37.
24. Petite H, Viateau V, Bensaid W et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000;
18:959-63.
Search WWH ::
Custom Search